Form 4 for RGA REINSURANCE GROUP OF AMERICA INC
Accepted 2023-11-13 00:00:00 ET · period of report 2023-11-10 · accession 0000898174-23-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-13 | 2023-11-10 | RGA | CARSON LAWRENCE S | EVP, GFS | M - OptEx | $124.45 | +3,975 | 17.5K | +29% | +$494.7K |
| DM | 2023-11-13 | 2023-11-10 | RGA | CARSON LAWRENCE S | EVP, GFS | F - Tax | $162.15 | -1,253 | 17.3K | -7% | -$203.2K |
| DM | 2023-11-13 | 2023-11-10 | RGA | CARSON LAWRENCE S | EVP, GFS | M - OptEx | $0.00 | -13.6K | 1,680 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-10 | M | A | 374 | $129.72 | 17,425 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-10 | F | D | 52 | $162.15 | 17,051 | D | — | — | (F3) 1. Represents (i) 1,560 shares sold to pay the exercise price the purchase of common stock, and (ii) 52 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 64 shares. |
| 3 | Common | Common Stock | 2023-11-10 | M | A | 421 | $106.53 | 17,680 | D | — | — | |
| 4 | Common | Common Stock | 2023-11-10 | F | D | 187 | $162.15 | 17,493 | D | — | — | (F5) 1. Represents (i) 806 shares sold to pay the exercise price the purchase of common stock, and (ii) 187 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 234 shares. |
| 5 | Common | Common Stock | 2023-11-10 | M | A | 1,449 | $129.01 | 18,942 | D | — | — | |
| 6 | Common | Common Stock | 2023-11-10 | F | D | 132 | $162.15 | 18,810 | D | — | — | (F6) 1. Represents (i) 1,153 shares sold to pay the exercise price the purchase of common stock, and (ii) 132 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 164 shares. |
| 7 | Common | Common Stock | 2023-11-10 | M | A | 116 | $150.87 | 17,103 | D | — | — | |
| 8 | Common | Common Stock | 2023-11-10 | F | D | 106 | $162.15 | 16,987 | D | — | — | (F2) 1. Represents (i) 2,055 shares sold to pay the exercise price the purchase of common stock, and (ii) 106 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 133 shares. |
| 9 | Common | Common Stock | 2023-11-10 | M | A | 239 | $145.25 | 17,093 | D | — | — | |
| 10 | Common | Common Stock | 2023-11-10 | F | D | 610 | $162.15 | 16,854 | D | — | — | (F1) 1. Represents (i) 3,663 shares sold to pay the exercise price the purchase of common stock, and (ii) 610 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 766 shares. |
| 11 | Common | Common Stock | 2023-11-10 | F | D | 166 | $162.15 | 17,259 | D | — | — | (F4) 1. Represents (i) 1,499 shares sold to pay the exercise price the purchase of common stock, and (ii) 166 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 208 shares. |
| 12 | Common | Common Stock | 2023-11-10 | M | A | 1,376 | $117.85 | 17,464 | D | — | — | |
| 13 | Derivative | Stock Appreciation Right (right to purchase) 2019 | 2023-11-10 | M | D | 2,294 | $0.00 | 0 | D | $145.25 · — to 2029-03-01 | 2,294 Common Stock | (F7) SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |
| 14 | Derivative | Stock Appreciation Right (right to purchase) 2021 | 2023-11-10 | M | D | 1,449 | $0.00 | 1,450 | D | $129.01 · — to 2031-03-11 | 1,449 Common Stock | (F7) SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |
| 15 | Derivative | Stock Appreciation Right (right to purchase) 2022 | 2023-11-10 | M | D | 1,227 | $0.00 | 3,683 | D | $106.53 · — to 2032-03-22 | 1,227 Common Stock | (F7) SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |
| 16 | Derivative | Stock Appreciation Right (right to purchase) 2017 | 2023-11-10 | M | D | 1,873 | $0.00 | 0 | D | $129.72 · — to 2027-03-03 | 1,873 Common Stock | (F7) SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |
| 17 | Derivative | Stock Appreciation Right (right to purchase) 2018 | 2023-11-10 | M | D | 1,676 | $0.00 | 0 | D | $150.87 · — to 2028-03-02 | 1,676 Common Stock | (F7) SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |
| 18 | Derivative | Stock Appreciation Right (right to purchase) 2020 | 2023-11-10 | M | D | 5,039 | $0.00 | 1,680 | D | $117.85 · — to 2030-03-06 | 5,039 Common Stock | (F7) SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |